Ireland
--:--IST
Recruiting Not applicable

Impact of Therapeutic Osteopathy-hypnosis on Cancer Patients.

NCT07860476 · tracked via the Priya Life Science France tracker
Sponsor
Institut Rafael
Phase
Not applicable
Started
2026-09-30
Last updated
2026-10-09

Condition(s) studied

Cancer

Investigational drug(s) / intervention(s)

OsteopathyHypnosis

Osteopathy: An osteopathy session includes a health history chat, physical assessment, hands-on treatment, and aftercare advice.

Hypnosis: Hypnosis sessions consisted in deep relaxation and focused concentration, delivered by practitioners trained in the therapy.

Study summary

Osteopathy is recognized as a beneficial complementary approach for cancer patients. By addressing tissue mobility, circulation, and muscle tension, it helps improve physical comfort, reduce musculoskeletal pain, and foster better functional recovery. Several studies have shown that osteopathy can help reduce pain intensity and improve the quality of life for patients undergoing cancer treatment.

Combining hypnosis with osteopathy could thus optimize treatment outcomes by integrating a holistic approach that addresses both physical and psychological needs. The aim of this study is to evaluate the impact of combined osteopathy and hypnosis treatment compared to osteopathic treatment alone in cancer patients, particularly regarding pain with a strong emotional component.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 years, * Patient diagnosed with cancer (currently undergoing treatment or having completed oncological treatment), * Experiencing chronic pain (≥ 3 months), * Presenting a strong emotional component to the pain: K10 score between 20 and 29, * Patient able to attend all visits and follow study procedures, * Patient who has provided consent. Exclusion Criteria: * Patients with no emotional distress or with severe distress * Sensory (auditory, visual) or cognitive deficits likely to hinder the conduct of hypnosis sessions * Patient who has undergone hypnotherapy sessions within the last 3 months * Patient unable to provide consent

Primary outcome measure(s)

  • Pain and quality of life — 6 weeks
    Change in pain and functional quality of life assessed between baseline (Day 0) and 6 weeks using the Brief Pain Inventory (BPI). • Calculation: The mean (average) of four items measuring pain in the last 24 hours or past week: worst pain, least pain, average pain, and current pain ("pain right now"). (Alternatively, a single item like "worst pain" can be evaluated on its own). • Scale Range: 0 to 10 (0 = "no pain", 10 = "pain as bad as you could imagine"). Cut-offs: 0 - 3: Mild pain, 4 - 6: Moderate pain, 7 - 10: Severe pain

Trial sites (1)

FacilityCityRegionStatus
Institut Rafael Levallois-Perret Île-de-France Region Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07860476 on ClinicalTrials.gov ↗ ← All trials in France